PLX107717

GSE137300: Immune effector monocyte - neutrophil cooperation induced by the primary tumor prevents metastatic progression of breast cancer

• Organsim mouse
• Type RNASEQ
• Target gene
• Project ARCHS4

Metastatic behaviour varies significantly among breast cancers. Mechanisms explaining why the majority of breast cancer patients never develop metastatic outgrowth are largely lacking but could underlie the development of novel immunotherapeutic target molecules. Here we show interplay between non-metastatic primary breast cancer and innate immune response, acting together to control metastatic progression. The primary tumor systemically recruits IFN-producing immune effector monocytes to the lung. IFN upregulates Tmem173/STING in neutrophils and enhances their killing capacity. The immune effector monocytes and tumoricidal Tmem173/STINGhigh neutrophils target disseminated tumor cells in the lungs, preventing metastatic outgrowth. Importantly, our findings could underlie the development of immunotherapeutic target molecules that augment the function of immune effector monocytes and Tmem173high neutrophils. SOURCE: Zena WerbHSW-1301 UCSF